6 reports of this reaction
1.8% of all BENZETHONIUM CHLORIDE reports
#11 most reported adverse reaction
PNEUMONIA is the #11 most commonly reported adverse reaction for BENZETHONIUM CHLORIDE, manufactured by McKesson. There are 6 FDA adverse event reports linking BENZETHONIUM CHLORIDE to PNEUMONIA. This represents approximately 1.8% of all 326 adverse event reports for this drug.
Patients taking BENZETHONIUM CHLORIDE who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for BENZETHONIUM CHLORIDE, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for BENZETHONIUM CHLORIDE:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 6 FDA reports for BENZETHONIUM CHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 1.8% of all adverse event reports for BENZETHONIUM CHLORIDE, making it a notable side effect.
If you experience pneumonia while taking BENZETHONIUM CHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.